Bernardo Haddock Lobo Goulart

4PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 24, 2024
Moving Immunotherapy Into the Treatment of Resectable Non-Small Cell Lung Cancer.

Jamie E Chaft, Rafal Dziadziuszko, Bernardo Haddock Lobo Goulart

|Jun 08, 2023
Continuation of Third-Generation Tyrosine Kinase Inhibitors in Second-Line Trials for

Bernardo H L Goulart, Erin Larkins, Julia A Beaver

|Feb 04, 2022
Impact of Diagnostic Delays on Lung Cancer Survival Outcomes: A Population Study of the US SEER-Medicare Database.

Perrin E Romine, Qin Sun, Catherine Fedorenko

|Aug 10, 2021
Effect of Clinical Trial Participation on Costs to Payers in Metastatic Non-Small-Cell Lung Cancer.

Cristina Merkhofer, Shasank Chennupati, Qin Sun

Pageof 1